123 related articles for article (PubMed ID: 30978322)
21. E-64c-Hydrazide Based Cathepsin C Inhibitors: Optimizing the Interactions with the S1'-S2' Area.
Tromsdorf N; Ullrich FTH; Rethmeier M; Sommerhoff CP; Schaschke N
ChemMedChem; 2023 Sep; 18(18):e202300218. PubMed ID: 37424408
[TBL] [Abstract][Full Text] [Related]
22. Olfactomedin 4 inhibits cathepsin C-mediated protease activities, thereby modulating neutrophil killing of Staphylococcus aureus and Escherichia coli in mice.
Liu W; Yan M; Liu Y; McLeish KR; Coleman WG; Rodgers GP
J Immunol; 2012 Sep; 189(5):2460-7. PubMed ID: 22844115
[TBL] [Abstract][Full Text] [Related]
23. The pharmacokinetic profile of brensocatib and its effect on pharmacodynamic biomarkers including NE, PR3, and CatG in various rodent species.
Basso J; Chen KJ; Zhou Y; Mark L; LaSala D; Dorfman A; Atalla M; Chun D; Viramontes V; Chang C; Leifer F; McDonald PP; Cipolla DC
Front Pharmacol; 2023; 14():1208780. PubMed ID: 37538173
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil Proteases Promote Experimental Abdominal Aortic Aneurysm via Extracellular Trap Release and Plasmacytoid Dendritic Cell Activation.
Yan H; Zhou HF; Akk A; Hu Y; Springer LE; Ennis TL; Pham CTN
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1660-1669. PubMed ID: 27283739
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin C inhibitors: property optimization and identification of a clinical candidate.
Furber M; Tiden AK; Gardiner P; Mete A; Ford R; Millichip I; Stein L; Mather A; Kinchin E; Luckhurst C; Barber S; Cage P; Sanganee H; Austin R; Chohan K; Beri R; Thong B; Wallace A; Oreffo V; Hutchinson R; Harper S; Debreczeni J; Breed J; Wissler L; Edman K
J Med Chem; 2014 Mar; 57(6):2357-67. PubMed ID: 24592859
[TBL] [Abstract][Full Text] [Related]
26. The crystal structure of human dipeptidyl peptidase I (cathepsin C) in complex with the inhibitor Gly-Phe-CHN2.
Mølgaard A; Arnau J; Lauritzen C; Larsen S; Petersen G; Pedersen J
Biochem J; 2007 Feb; 401(3):645-50. PubMed ID: 17020538
[TBL] [Abstract][Full Text] [Related]
27. Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease.
Chalmers JD; Kettritz R; Korkmaz B
Front Immunol; 2023; 14():1239151. PubMed ID: 38162644
[TBL] [Abstract][Full Text] [Related]
28. Cathepsin C inhibitors as anti-inflammatory drug discovery: Challenges and opportunities.
Shen XB; Chen X; Zhang ZY; Wu FF; Liu XH
Eur J Med Chem; 2021 Dec; 225():113818. PubMed ID: 34492551
[TBL] [Abstract][Full Text] [Related]
29. Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660).
Miller BE; Mayer RJ; Goyal N; Bal J; Dallow N; Boyce M; Carpenter D; Churchill A; Heslop T; Lazaar AL
Br J Clin Pharmacol; 2017 Dec; 83(12):2813-2820. PubMed ID: 28800383
[TBL] [Abstract][Full Text] [Related]
30. Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design.
Greenspan PD; Clark KL; Tommasi RA; Cowen SD; McQuire LW; Farley DL; van Duzer JH; Goldberg RL; Zhou H; Du Z; Fitt JJ; Coppa DE; Fang Z; Macchia W; Zhu L; Capparelli MP; Goldstein R; Wigg AM; Doughty JR; Bohacek RS; Knap AK
J Med Chem; 2001 Dec; 44(26):4524-34. PubMed ID: 11741472
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological inhibition of cathepsin C (CatC) as a potential approach for cancer therapeutics.
Abideen SA; Khan M; Al-Harbi AI; Ahmad S
J Biomol Struct Dyn; 2023; 41(18):8682-8689. PubMed ID: 36264138
[TBL] [Abstract][Full Text] [Related]
32. Lysosomal peptidases and glycosidases in rheumatoid arthritis.
Sohar N; Hammer H; Sohar I
Biol Chem; 2002 May; 383(5):865-9. PubMed ID: 12108554
[TBL] [Abstract][Full Text] [Related]
33. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis.
Izmailova ES; Paz N; Alencar H; Chun M; Schopf L; Hepperle M; Lane JH; Harriman G; Xu Y; Ocain T; Weissleder R; Mahmood U; Healy AM; Jaffee B
Arthritis Rheum; 2007 Jan; 56(1):117-28. PubMed ID: 17195214
[TBL] [Abstract][Full Text] [Related]
34. Papillon-Lefèvre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans.
Pham CT; Ivanovich JL; Raptis SZ; Zehnbauer B; Ley TJ
J Immunol; 2004 Dec; 173(12):7277-81. PubMed ID: 15585850
[TBL] [Abstract][Full Text] [Related]
35. Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.
Tavares FX; Boncek V; Deaton DN; Hassell AM; Long ST; Miller AB; Payne AA; Miller LR; Shewchuk LM; Wells-Knecht K; Willard DH; Wright LL; Zhou HQ
J Med Chem; 2004 Jan; 47(3):588-99. PubMed ID: 14736240
[TBL] [Abstract][Full Text] [Related]
36. Dipeptidyl nitriles as human dipeptidyl peptidase I inhibitors.
Bondebjerg J; Fuglsang H; Valeur KR; Pedersen J; Naerum L
Bioorg Med Chem Lett; 2006 Jul; 16(13):3614-7. PubMed ID: 16647256
[TBL] [Abstract][Full Text] [Related]
37. Cathepsins L and S are not required for activation of dipeptidyl peptidase I (cathepsin C) in mice.
Mallen-St Clair J; Shi GP; Sutherland RE; Chapman HA; Caughey GH; Wolters PJ
Biol Chem; 2006 Aug; 387(8):1143-6. PubMed ID: 16895486
[TBL] [Abstract][Full Text] [Related]
38. Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C).
Kam CM; Götz MG; Koot G; McGuire M; Thiele D; Hudig D; Powers JC
Arch Biochem Biophys; 2004 Jul; 427(2):123-34. PubMed ID: 15196986
[TBL] [Abstract][Full Text] [Related]
39. Processing and Maturation of Cathepsin C Zymogen: A Biochemical and Molecular Modeling Analysis.
Lamort AS; Hamon Y; Czaplewski C; Gieldon A; Seren S; Coquet L; Lecaille F; Lesner A; Lalmanach G; Gauthier F; Jenne D; Korkmaz B
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557781
[TBL] [Abstract][Full Text] [Related]
40. A novel class of nonpeptidic biaryl inhibitors of human cathepsin K.
Robichaud J; Oballa R; Prasit P; Falgueyret JP; Percival MD; Wesolowski G; Rodan SB; Kimmel D; Johnson C; Bryant C; Venkatraman S; Setti E; Mendonca R; Palmer JT
J Med Chem; 2003 Aug; 46(17):3709-27. PubMed ID: 12904076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
